Heparin albumin containing adsorbents for hemoperfusion

The technology was developed in Ukrainian academic research center, which was established in 1960 and is a part of Ukrainian Academy of Sciences Preliminary studies on development of heparin- protein-carbon adsorbent with a permeable coating demonstrated very high adsorptive capacity towards unconjugated bilirubin (more than 200 mg/g of carbon matrix) (Fig.1) that is several times higher than the capacity of state-of-the-art deligandizing hemoadsorbents. Heparin presence in the coating not only enhances biocompatibility but attaches selectivity to hemoadsorbents towards heparin (DNA) –binding proteins as anti-ss-DNA and anti-n-DNA antibodies . Selectivity of heparin containing charcoal to anti-ss-DNA AT 1.5 0.2( n=19) is significantly higher than those of uncoated charcoal 1.10.2 (n=31), idem for anti-n-DNA AT 1.60.18 (n=6) and 1.0 0.18(n=6). Albumin-heparin containing hemoadsorbents will be developed and tested in vitro, in vivo systems (preclinical studies). This adsorbent disposable in plastic columns (200 cc and 400 cc capacities) will be applied for treatment of acute and chronic hepatic insufficiencies and in cases of intoxication with hydrophobic poisons. Looking for research centers, universities, big pharmaceutical companies for joint preclinical and clinical studies. Different collaboration options including research cooperation agreement are available depending on the partners' expertise.